Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 2, 2005, Pages 133-140

  Aivado, Manuel ^a,b   Spentzos, Dimitrios ^a   Alterovitz, Gil ^c,d   Otu, Hasan H ^a   Grall, Franck ^a   Giagounidis, Aristoteles A N ^b   Wells, Meghan ^a   Cho, Je Yoel ^a,e   Germing, Ulrich ^b   Czibere, Akos ^a   Prall, Wolf C ^a   Porter, Chris ^a   Ramoni, Marco F ^d   Libermann, Towia A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e Kyungpook National University   (South Korea)

Author keywords

High throughput; Plasma protein profiling; Proteomics; Serum protein profiling; Surface enhanced laser desorption ionization time of flight mass spectrometry (SELDI TOF MS)

Indexed keywords

ARTICLE; AUTOMATION; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC TEST; HUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN BLOOD LEVEL; PROTEIN MICROARRAY; RELIABILITY; ROBOTICS; SIGNAL NOISE RATIO; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

LASERS; PROTEIN ARRAY ANALYSIS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 20144372083     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2005.022     Document Type: Article

References (18)

1. Hutchens TW, Yip TT. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 1993;7:576-80.
2. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-7.
3. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002;62:3609-14.
4. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002;48:1296-1304.
5. Poon TC, Yip TT, Chan AT, Yip C, Yip V, Mok TS, et al. Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 2003;49:752-60.
6. Kozak KR, Amneus MW, Pusey SM, Su F, Luong MN, Luong SA, et al. Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis. Proc Natl Acad Sci USA 2003;100:12343-8.
7. Banez LL, Prasanna P, Sun L, Ali A, Zou Z, Adam BL, et al. Diagnostic potential of serum proteomic patterns in prostate cancer. J Urol 2003;170:442-6.
8. Hanash S. Disease proteomics. Nature 2003;422:226-32.
9. Fung ET, Enderwick C. ProteinChip clinical proteomics: computational challenges and solutions. Biotechniques 2002;Suppl:34-8, 40-1.
10. Cordingley HC, Roberts SL, Tooke P, Armitage JR, Lane PW, Wu W, et al. Multifactorial screening design and analysis of SELDI-TOF ProteinChip array optimization experiments. Biotechniques 2003;34:364-5, 368-3.
11. Sorace JM, Zhan M. A data review and re-assessment of ovarian cancer serum proteomic profiling. BMC Bioinformatics 2003;4:24.
12. Lee ML, Kuo FC, Whitmore GA, Sklar J. Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. Proc Natl Acad Sci USA 2000;97:9834-9.
13. Black MA, Doerge RW. Calculation ofthe minimum number of replicate spots required for detection of significant gene expression fold change in microarray experiments. Bioinformatics 2002;18:1609-16.
14. Rogers MA, Clarke P, Noble J, Munro NP, Paul A, Selby PJ, et al. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. Cancer Res 2003; 63:6971-83.
15. Holmes MD, Pollak MN, Hankinson SE. Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 2002;11:862-7.
16. BIDMC Genomics Center. www.bidmcgenomics.org/Seldi-Tof.
17. Sneath PHA. Numerical Taxonomy: The principles and practice of numerical classification. San Francisco, CA, USA: WH Freeman, 1973.
18. Boguski MS, McIntosh MW. Biomedical informatics for proteomics. Nature 2003,422:233-7.